Wikipedia:Articles for deletion/Chlorpheniramine and phenylpropanolamine


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was   No consensus to delete. There was no support for totally removing this material. Even the Delete voters implied that the material should find a home in one of the articles of the parent drugs. If coverage does move elsewhere thanks to the normal editorial process, the name Chlorpheniramine and phenylpropanolamine could become a redirect to whatever article section the material ends up in. EdJohnston (talk) 02:03, 21 May 2008 (UTC)

Chlorpheniramine and phenylpropanolamine

 * ( [ delete] ) – (View AfD) (View log)

This drug combination doesn't warrant its own page. It should be included in the chlorpheniramine article. See Butalbital for an example of a good list of drug combinations centralized on one page. See also Paracetamol/metoclopramide for a similar, but more notable, article about a drug combo (which also recently survived Afd). Fuzzform (talk) 20:48, 12 May 2008 (UTC)

Also, this article is what I'd call a "permanent stub". It contains all the information it will ever contain, so it's logical to move it somewhere else (and perhaps provide redirects for the brandnames listed). Fuzzform (talk) 20:51, 12 May 2008 (UTC)
 * Delete per a well-reasoned nomination. If there is any information of independent value here (which I don't see), it could easily be included in chlorpheniramine. GoogleScholar returns only a small number of hits. A merge and redirect to chlorpheniramine is also a possibility. Nsk92 (talk) 22:46, 12 May 2008 (UTC)
 * Delete Drug combos should only be articles if they have received significant coverage as to the drugs in combination as opposed to other drugs/combinations. It might be a good idea for WP:DRUG to become a notablility policy. ScienceApologist (talk) 15:28, 13 May 2008 (UTC)
 * Delete per Fuzzform. Stifle (talk) 19:17, 13 May 2008 (UTC)
 * Keep very widely used over the counter medicine under multiple brand names, all very well known, all suitable for redirects. suitable to be kept.  There is also a good deal of specific literature about this specific combination.  We should have a notabillity policy for these drugs, and should include ones like this.DGG (talk) 02:55, 14 May 2008 (UTC)
 * Note: This debate has been included in the list of Medicine-related deletion discussions.   -- Fabrictramp (talk) 20:46, 14 May 2008 (UTC)
 * PubMed coverage of this: using the article title here, "Chlorpheniramine and phenylpropanolamine": 99 papers, dealing with the analysis or the hazards of the combination. DGG (talk) 00:05, 15 May 2008 (UTC)
 * Keep per DGG. That there are papers dealing specifically with this combination, and there are multiple brand names for this combination, suggests to me that this is a notable combination. Same as rum and coke. :-) --Itub (talk) 13:32, 20 May 2008 (UTC)
 * Merge to Chlorphenamine. No need to lose the content but there is no point in keeping as a separate page what would be a permastub. TerriersFan (talk) 20:35, 20 May 2008 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.